BiocardiaBCDA
13F holders, Q3 2024 (September 30)9holders
1new positions
1sold out
$3.12avg. 13F price*
At the end of Q3 2024, 9 institutions reported holding Biocardia Inc. (BCDA) in their 13F filings, unchanged from Q2 2024. 1 opened new positions and 1 sold out. The largest holders were Susquehanna International Group, LLP ($220K), Geode Capital Management, LLC ($46K) and Vanguard Group Inc. ($40K).
- Company
- Biocardia Inc.
- CUSIP
- 09060U606
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $190 |
| Exits | 1 | $0 |
All 13F filers, Q2 2024 → Q3 2024: 27,817 shares bought and 1,780 shares sold, net +26,037 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 9 holders
| Susquehanna International Group, LLP | 0.00% | Add +58.4% | 70,596 | $220K |
| Geode Capital Management, LLC | 0.00% | Add +13.2% | 14,736 | $46K |
| Vanguard Group Inc. | 0.00% | No change | 12,884 | $40K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -57.8% | 1,282 | $4K |
| Pingora Partners LLC | 0.00% | No change | 1,036 | $3K |
| Bank of America Corp. | 0.00% | Add +0.5% | 446 | $1K |
| Global Retirement Partners, LLC | 0.00% | No change | 411 | $1K |
| Osaic Holdings, Inc. | 0.00% | New | 61 | $190 |
| Morgan Stanley | 0.00% | No change | 30 | $94 |
"% of holder's portfolio" is BCDA's weight in each manager's 13F, not the share of Biocardia Inc. the manager owns.